RGS17 and ovarian cancer: For example, RGS10 and RGS17 knockdown conferred cisplatin-resistance in ovarian cancer cells [96], whereas increasing RGS17 in nasopharyngeal cancer improves sensitivity to 5-fluorouracil [97].